Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Sep 24, 2015; 5(3): 81-88
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.81
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.81
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas
Narendranath Epperla, Timothy S Fenske, Parameswaran N Hari, Mehdi Hamadani, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, United States
Author contributions: Epperla N and Hamadani M designed research; Epperla N and Hamadani M performed research; Epperla N and Hamadani M analyzed data; Epperla N, Fenske TS, Hari PN and Hamadani M wrote the paper.
Conflict-of-interest statement: The authors report no relevant conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Mehdi Hamadani, MD, Associate Professor, Division of Hematology and Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, United States. mhamadani@mcw.edu
Telephone: +1-414-8050643 Fax: +1-414-8056815
Received: April 14, 2015
Peer-review started: April 14, 2015
First decision: May 13, 2015
Revised: May 27, 2015
Accepted: June 18, 2015
Article in press: June 19, 2015
Published online: September 24, 2015
Processing time: 163 Days and 14.3 Hours
Peer-review started: April 14, 2015
First decision: May 13, 2015
Revised: May 27, 2015
Accepted: June 18, 2015
Article in press: June 19, 2015
Published online: September 24, 2015
Processing time: 163 Days and 14.3 Hours
Core Tip
Core tip: Prevention of disease-relapse is an unmet medical need in B-cell non-Hodgkin lymphomas (NHL) undergoing autologous hematopoietic cell transplantation (auto-HCT). In this review, are summarized potentially paradigm changing advances in post auto-HCT, maintenance strategies in B-cell NHL.